11.04.20
For the third quarter of 2020, Ontex reported revenue of €508 million ($594 million), down 12% compared to the third quarter of 2019, including a €43 million ($50 million) negative currency impact; and -4.6% like-for-like (LFL) on the back of lower personal hygiene market demand and increased competition.
The Q3 2020 reported revenue of €508 million ($594 million) did however mark a €29 million ($34 million) improvement versus Q2 2020, with demand slowly recovering following the initial pandemic-related demand surge and subsequent decrease in H1.
Ontex Babycare revenue decreased 8.5% in Q3 2020 versus the same period last year, due to lower volumes. While market demand in the Babycare category has improved since the summer compared with pandemic-induced pantry loading and subsequent unwinding in its markets, it was below trends observed prior to the impact of Covid-19 which became visible in our markets at the end of Q1. Baby pants outperformed baby diapers in the quarter.
Q3 2020 Adult Incontinence (Adult Inco) revenue increased, up +2.7% year-on-year. Sales of Adult Inco products in retail channels grew by 10%, with both Europe and AMEAA Divisions posting higher revenue. Adult Inco sales in institutional channels were below last year, as Covid-19 impacts resulted in lower demand in hospitals and care homes. Sales of Adult pants were well ahead of overall category growth.
Revenue of Feminine Care products was down 6.7% in Q3 2020 versus prior year. The majority of Ontex’s Feminine Care sales are in Europe, where market demand was visibly lower than the same period a year ago. Reported revenue was positively impacted by sales to retailer customers in the U.S., following completion of the Albaad Feminine Care acquisition on July 1 and subsequent consolidation in its results.
The Q3 2020 reported revenue of €508 million ($594 million) did however mark a €29 million ($34 million) improvement versus Q2 2020, with demand slowly recovering following the initial pandemic-related demand surge and subsequent decrease in H1.
Ontex Babycare revenue decreased 8.5% in Q3 2020 versus the same period last year, due to lower volumes. While market demand in the Babycare category has improved since the summer compared with pandemic-induced pantry loading and subsequent unwinding in its markets, it was below trends observed prior to the impact of Covid-19 which became visible in our markets at the end of Q1. Baby pants outperformed baby diapers in the quarter.
Q3 2020 Adult Incontinence (Adult Inco) revenue increased, up +2.7% year-on-year. Sales of Adult Inco products in retail channels grew by 10%, with both Europe and AMEAA Divisions posting higher revenue. Adult Inco sales in institutional channels were below last year, as Covid-19 impacts resulted in lower demand in hospitals and care homes. Sales of Adult pants were well ahead of overall category growth.
Revenue of Feminine Care products was down 6.7% in Q3 2020 versus prior year. The majority of Ontex’s Feminine Care sales are in Europe, where market demand was visibly lower than the same period a year ago. Reported revenue was positively impacted by sales to retailer customers in the U.S., following completion of the Albaad Feminine Care acquisition on July 1 and subsequent consolidation in its results.